All In Biotech

Free tool

FAERS Monitor: Sezaby

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215910 or its brand name (Sezaby, Phenobarbital Sodium). Reports on generic versions are filed under their own applications.

Reports

416

Serious

405

97% of reports

Hospitalization

215

Death reported

62

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure68
  • off label use60
  • drug ineffective58
  • epilepsy27
  • status epilepticus21
  • product use in unapproved indication19
  • pallor18
  • sepsis18
  • drug ineffective for unapproved indication17
  • condition aggravated16
  • confusional state15
  • drug resistance15
  • fall15
  • pyrexia15
  • death14

Reports by year received

View as table
YearReports
20045
20056
20071
20081
20092
20117
20126
201315
201410
201512
201619
201712
201850
201937
202019
202134
202237
202340
202441
202529
202630

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,743 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
status epilepticusSignal2194.262.11,842
epilepsySignal2744.731.01,111
pallorSignal1833.521.3535
seizureSignal6829.824.01,872
drug resistanceSignal1529.518.0386
drug ineffective for unapproved indicationSignal1715.79.8220
sepsisSignal188.25.2107
confusional stateSignal154.72.940
product use in unapproved indicationSignal193.92.538
off label useSignal603.52.7107
condition aggravatedSignal162.71.615
fallSignal152.31.410
drug ineffectiveSignal582.21.840
pyrexiaSignal152.21.39
death140.80.50

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.